Warning: The NCBI web site requires JavaScript to function. more...
Effects of monoclonal anti-PcrV antibody on Pseudomonas aeruginosa-induced acute lung injury in a rat model.
Faure K, Fujimoto J, Shimabukuro DW, Ajayi T, Shime N, Moriyama K, Spack EG, Wiener-Kronish JP, Sawa T.
J Immune Based Ther Vaccines. 2003 Aug 13;1(1):2.
Related citations
Therapeutic administration of anti-PcrV F(ab')(2) in sepsis associated with Pseudomonas aeruginosa.
Shime N, Sawa T, Fujimoto J, Faure K, Allmond LR, Karaca T, Swanson BL, Spack EG, Wiener-Kronish JP.
J Immunol. 2001 Nov 15;167(10):5880-6.
PcrV antibody-antibiotic combination improves survival in Pseudomonas aeruginosa-infected mice.
Song Y, Baer M, Srinivasan R, Lima J, Yarranton G, Bebbington C, Lynch SV.
Eur J Clin Microbiol Infect Dis. 2011 Dec 21. [Epub ahead of print]
Effects of antibiotic therapy on Pseudomonas aeruginosa-induced lung injury in a rat model.
Ernst EJ, Hashimoto S, Guglielmo J, Sawa T, Pittet JF, Kropp H, Jackson JJ, Wiener-Kronish JP.
Antimicrob Agents Chemother. 1999 Oct;43(10):2389-94.
Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model.
Imamura Y, Yanagihara K, Fukuda Y, Kaneko Y, Seki M, Izumikawa K, Miyazaki Y, Hirakata Y, Sawa T, Wiener-Kronish JP, Kohno S.
Eur Respir J. 2007 May;29(5):965-8. Epub 2007 Feb 14.
Pseudomonas aeruginosa-induced lung and pleural injury in sheep. Differential protective effect of circulating versus alveolar immunoglobulin G antibody.
Pittet JF, Matthay MA, Pier G, Grady M, Wiener-Kronish JP.
J Clin Invest. 1993 Sep;92(3):1221-8.
Pseudomonas aeruginosa causes acute lung injury via the catalytic activity of the patatin-like phospholipase domain of ExoU.
Pankhaniya RR, Tamura M, Allmond LR, Moriyama K, Ajayi T, Wiener-Kronish JP, Sawa T.
Crit Care Med. 2004 Nov;32(11):2293-9.
Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV.
Frank DW, Vallis A, Wiener-Kronish JP, Roy-Burman A, Spack EG, Mullaney BP, Megdoud M, Marks JD, Fritz R, Sawa T.
J Infect Dis. 2002 Jul 1;186(1):64-73. Epub 2002 Jun 14.
TLR4 signaling is essential for survival in acute lung injury induced by virulent Pseudomonas aeruginosa secreting type III secretory toxins.
Faure K, Sawa T, Ajayi T, Fujimoto J, Moriyama K, Shime N, Wiener-Kronish JP.
Respir Res. 2004 Feb 12;5:1.
Protection against Pseudomonas aeruginosa pneumonia and sepsis-induced lung injury by overexpression of beta-defensin-2 in rats.
Shu Q, Shi Z, Zhao Z, Chen Z, Yao H, Chen Q, Hoeft A, Stuber F, Fang X.
Shock. 2006 Oct;26(4):365-71.
Polymorphisms in the Pseudomonas aeruginosa type III secretion protein, PcrV - implications for anti-PcrV immunotherapy.
Lynch SV, Flanagan JL, Sawa T, Fang A, Baek MS, Rubio-Mills A, Ajayi T, Yanagihara K, Hirakata Y, Kohno S, Misset B, Nguyen JC, Wiener-Kronish JP.
Microb Pathog. 2010 Jun;48(6):197-204. Epub 2010 Mar 6.
The effects of two antiinflammatory pretreatments on bacterial-induced lung injury.
Miyazaki H, Broaddus VC, Wiener-Kronish JP, Sawa T, Pittet JF, Kravchenko V, Mathison JC, Nishizawa H, Hattori S, Yamakawa T, Yamada H, Kudoh I.
Anesthesiology. 1999 Jun;90(6):1650-62.
Alveolar epithelial injury and pleural empyema in acute P. aeruginosa pneumonia in anesthetized rabbits.
Wiener-Kronish JP, Sakuma T, Kudoh I, Pittet JF, Frank D, Dobbs L, Vasil ML, Matthay MA.
J Appl Physiol. 1993 Oct;75(4):1661-9.
Effects of intratracheal administration of novispirin G10 on a rat model of mucoid Pseudomonas aeruginosa lung infection.
Song Z, Wu H, Mygind P, Raventos D, Sonksen C, Kristensen HH, Høiby N.
Antimicrob Agents Chemother. 2005 Sep;49(9):3868-74.
Pseudomonas aeruginosa-specific IgG1 and IgG2 subclasses in enhancement of pulmonary clearance following passive immunisation in the rat.
Dunkley ML, Rajyaguru S, McCue A, Cripps AW, Kyd JM.
FEMS Immunol Med Microbiol. 2003 Oct 24;39(1):37-44.
Apoptosis inhibition in P. aeruginosa-induced lung injury influences lung fluid balance.
Le Berre R, Faure K, Fauvel H, Viget NB, Ader F, Prangère T, Thomas AM, Leroy X, Pittet JF, Marchetti P, Guery BP.
Intensive Care Med. 2004 Jun;30(6):1204-11. Epub 2004 Feb 26.
Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia.
Kurahashi K, Kajikawa O, Sawa T, Ohara M, Gropper MA, Frank DW, Martin TR, Wiener-Kronish JP.
J Clin Invest. 1999 Sep;104(6):743-50.
Role of integrin alphav beta6 in acute lung injury induced by Pseudomonas aeruginosa.
Song Y, Pittet JF, Huang X, He H, Lynch SV, Violette SM, Weinreb PH, Horan GS, Carmago A, Sawa Y, Bernstein XL, Wiener-Kronish JP.
Infect Immun. 2008 Jun;76(6):2325-32. Epub 2008 Mar 31.
Intravenous administration of activated protein C in Pseudomonas-induced lung injury: impact on lung fluid balance and the inflammatory response.
Robriquet L, Collet F, Tournoys A, Prangère T, Nevière R, Fourrier F, Guery BP.
Respir Res. 2006 Mar 22;7:41.
Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge.
Neely AN, Holder IA, Wiener-Kronish JP, Sawa T.
Burns. 2005 Mar;31(2):153-8.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on